CPC
ARRY

Cookson Peirce & Co’s Array Biopharma Inc ARRY Stock Holding History

Cookson Peirce & Co’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,990
Closed -$61K – 145
2014
Q4 		$61K Buy
+12,990
New +$51.4K 0.01% 116

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cookson Peirce & Co's ARRY Position: Q1 2015 in Review

Cookson Peirce & Co sold out of Array Biopharma Inc (ARRY) in Q1 2015, closing a stake of 12,990 shares — an estimated $61K sold.

Cookson Peirce & Co first reported a position in ARRY in Q4 2014 and held it in 1 quarter. The position peaked at $61K in Q4 2014. 133 funds tracked by Wall St. Rank hold ARRY as of Q1 2015.

  • Cookson Peirce & Co reported no remaining Array Biopharma Inc position as of Q1 2015 after selling out during the quarter.
  • Cookson Peirce & Co sold 12,990 Array Biopharma Inc shares in Q1 2015, an estimated $61K.
  • Cookson Peirce & Co first reported a position in Array Biopharma Inc in Q4 2014 and held it in 1 quarter.
  • Cookson Peirce & Co's Array Biopharma Inc position peaked at $61K in Q4 2014.
  • 133 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2015.

Based on Cookson Peirce & Co's 13F filing for Q1 2015, filed 6 May 2015.